Session Details

U028 Lasers & Energy Devices in the Treatment of Acne

Sat, Mar 20, 7:30 AM - 8:30 AM
1 CME Available Focus Session

DESCRIPTION

Acne vulgaris is the most common skin disorder in Dermatology. Medical therapy is considered first-line in the treatment of all forms of acne, including inflammatory, comedonal and nodulocystic types. Recently, new technology has been developed to address acne and acne scarring. This session will review the published literature on the various lasers and energy devices used in the treatment of acne vulgaris and acne scarring, along with algorithms that incorporate medical therapies. Safety protocols will be reviewed, including the use of these devices in diverse racial skin types.

LEARNING OBJECTIVES

1.

Discuss the various lasers and energy devices that are available for the treatment of acne and acne scarring.

2.

Select the appropriate laser or energy device for acne/acne scarring patients with diverse skin types.

3.

Describe an algorithm that incorporates lasers/energy devices with medical therapies for acne/acne scarring patients.

SCHEDULE

7:30 AM

Introduction

DIRECTOR

Valerie D. Callender, MD, FAAD

Valerie D. Callender, MD, FAAD

Founder & Medical Director, Callender Dermatology& Cosmetic Center, Howard University College of Medicine

SPEAKERS

Glynis R. Ablon, MD, FAAD

Glynis R. Ablon, MD, FAAD

Associate Clin Prof UCLA

Fernanda H. Sakamoto, MD, PhD

Fernanda H. Sakamoto, MD, PhD

DISCLOSURES

Glynis R. Ablon, MD, FAAD

Bausch Health – Investigator(Grants/Research Funding); Benev – Investigator(Grants/Research Funding); Eli Lilly – Investigator(Grants/Research Funding); Everwell Health Solutions – Investigator(Grants/Research Funding); Galderma Laboratories, L.P. – Investigator(Grants/Research Funding); L'Oreal – Investigator(Grants/Research Funding); Nutrafol – Investigator(Grants/Research Funding); Pelage – Investigator(Grants/Research Funding); Veradermics – Investigator(Grants/Research Funding);

Valerie D. Callender, MD, FAAD

Aerolase – Advisory Board(Stock Options), Speaker/Faculty Education(Honoraria); Altree – Stockholder Private Company(Stock Options); Arcutis Biotherapeutics – Speaker(Honoraria); Beiersdorf, Inc. – Speaker(Honoraria); Callender Center for Clinical Research – Founder(No Compensation Received); Eli Lilly – Speaker/Faculty Education(Honoraria); Eli Lilly and Company – Investigator(Grants/Research Funding); Elsevier Inc. – Independent Contractor(Honoraria); Incyte – Investigator(Grants/Research Funding); Janssen Biotech – Investigator(Grants/Research Funding); L'Oreal USA Inc. – Consultant(Honoraria), Investigator(Honoraria); La Roche-Posay - L'Oreal Group – Advisory Board(Honoraria); Ortho Dermatologics – Advisory Board(Honoraria); Pfizer Inc. – Advisory Board(Honoraria), Investigator(Grants/Research Funding); Prollenium Medical Technologies – Investigator(Grants/Research Funding); Regeneron Pharmaceuticals Inc – Investigator(Grants/Research Funding); Restore Biologics – Advisory Board(Honoraria); Sinclair Pharma – Investigator(Grants/Research Funding); SkinCeuticals LLC – Advisory Board(Honoraria), Speaker(Honoraria); symatese – Investigator(Grants/Research Funding); TEOXANE Laboratories – Investigator(Grants/Research Funding); Unilever – Advisory Board(Honoraria); UpToDate – Other(Patent royalties or other compensation for Intellectual Property Rights); Veradermics – Advisory Board(Honoraria); VeraDermics Inc. – Investigator(Grants/Research Funding); WoltersKluwer Health – Independent Contractor(Patent royalties or other compensation for Intellectual Property Rights);

Fernanda H. Sakamoto, MD, PhD

Accure Medical, LLC – Advisory Board(Patent royalties or other compensation for Intellectual Property Rights); AVAVA, LLC – Advisory Board(Patent royalties or other compensation for Intellectual Property Rights); Beiersdorf, Inc. – Advisory Board(Honoraria); Blossom Innovations, LLC – Founder(Patent royalties or other compensation for Intellectual Property Rights); Cytrellis Biosystems, Inc – Advisory Board(Patent royalties or other compensation for Intellectual Property Rights); Follica – Advisory Board(Patent royalties or other compensation for Intellectual Property Rights); Lightwater Biosciences, Inc. – Advisory Board(No Compensation Received), Advisory Board(Stock Options); R2 Dermatology, Inc. – Advisory Board(Stock); Seventh Sense BioSystems – Advisory Board(Stock); Sofregen Medical, Inc. – Advisory Board(Stock);